- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Potential repurposing of oncology drugs for the treatment of Alzheimer's disease ; volume:11 ; number:1 ; day:26 ; month:3 ; year:2013 ; pages:1-3 ; date:12.2013
BMC medicine ; 11, Heft 1 (26.3.2013), 1-3, 12.2013
- Creator
-
Araki, Wataru
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1741-7015-11-82
- URN
-
urn:nbn:de:1111-2016072226494
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Araki, Wataru
- SpringerLink (Online service)
Other Objects (12)
Drug Repurposing in Oncology
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Single-cell-led drug repurposing for Alzheimer’s disease
Drug repurposing
Repurposing of approved cardiovascular drugs
Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Drug repurposing in cardiology
Applications of Artificial Intelligence in Drug Repurposing
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes
Drug Repurposing in Oncology
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Single-cell-led drug repurposing for Alzheimer’s disease
Drug repurposing
Repurposing of approved cardiovascular drugs
Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Drug repurposing in cardiology
Applications of Artificial Intelligence in Drug Repurposing
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes
Drug Repurposing in Oncology
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Single-cell-led drug repurposing for Alzheimer’s disease
Drug repurposing
Repurposing of approved cardiovascular drugs
Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Drug repurposing in cardiology
Applications of Artificial Intelligence in Drug Repurposing
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects